Simulations Plus

Simulations Plus develops biosimulation software and provides consulting services, integrating AI/machine learning with advanced pharmacokinetic and pharmacodynamic modeling. Core tools include physiologically based pharmacokinetic (PBPK), quantitative systems pharmacology (QSP), and cheminformatics, supporting decision-making across drug discovery, development, and clinical operations. Their offerings aim to optimize research and development processes within the pharmaceutical industry.

Walter Woltosz founded Simulations Plus in 1996 in Lancaster, California. His insight was to apply computational modeling and simulation to accelerate and refine drug development. Woltosz aimed to equip pharmaceutical and biotechnology companies with predictive tools for drug behavior and effects, thereby reducing dependence on expensive, protracted experimental methods and improving efficiency in bringing new drugs to market.

The company's products and services serve pharmaceutical, biotechnology, and academic researchers globally. Simulations Plus envisions its modeling and simulation technologies continuously enhancing scientific understanding and prediction, facilitating more efficient and successful therapy development. Its mission centers on advancing health outcomes via innovative, data-driven solutions for the life sciences industry.